stock
RNAZ · Transcode Therapeutics, Inc.
What Transcode Therapeutics, Inc. reports to the SEC, read from its filings.
Open in the appPrice
The live RNAZ price and today's change.
Sign in to see thisChart
Thirty days of daily bars, with signal levels drawn on them.
Sign in to see thisSignals
The latest signal group Nakagai's scanner recorded on RNAZ.
Sign in to see thisOptions positioning
Gamma exposure levels from the options market.
Sign in to see thisTechnicals
Trend, momentum and volatility gauges per timeframe.
Sign in to see thisWhat it is
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Filer (SEC EDGAR)
- EDGAR filing index
- Shares outstanding
- 16,930,739 as of 2026-08-10 (XBRL frame CY2026Q2I)
Key stats
Valuation
- P/E
- Locked
- P/S
- Locked
- P/B
- Locked
- Enterprise value
- Locked
- EV/EBIT
- Locked
- FCF yield
- Locked
Margins
- Gross
- —
- Operating
- —
- Net
- —
Returns
- ROE
- —
- ROA
- -28.4%
Health
- Current ratio
- 2.0x
- Debt/equity
- —
Deep value
- NCAV
- -$2.01M
- NCAV per share
- -$0.12
- Price/NCAV
- Locked
- NNWC
- -$4.27M
- NNWC per share
- -$0.25
- Price/NNWC
- Locked
Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.
Sign in to see thisDebt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.
Results
| Period end | Revenue (not reported by this company) | Gross profit (not reported by this company) | Operating income | Net income | Filing |
|---|---|---|---|---|---|
| 2026-06-30 | —Revenue: unreported by this company. | —Gross profit: unreported by this company. | -$6.79M | -$6.75M | 10-Q filed 2026-08-14 |
| 2026-03-31 | —Revenue: unreported by this company. | —Gross profit: unreported by this company. | -$17.76M | -$17.79M | 10-Q filed 2026-08-14 Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-12-31 | —Revenue: unreported by this company. | —Gross profit: unreported by this company. | -$16.03M | -$13.44M | 10-K filed 2026-04-15 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. |
| 2025-09-30 | —Revenue: unreported by this company. | —Gross profit: unreported by this company. | -$4.56M | -$4.86M | 10-Q filed 2025-11-14 |
| 2025-06-30 | —Revenue: unreported by this company. | —Gross profit: unreported by this company. | -$4.22M | -$4.28M | 10-Q filed 2026-08-14 |
| 2025-03-31 | —Revenue: unreported by this company. | —Gross profit: unreported by this company. | -$3.17M | -$12.09M | 10-Q filed 2026-08-14 Assembled from more than one filing; the filing above is only the newest of them. |
| 2024-12-31 | —Revenue: unreported by this company. | —Gross profit: unreported by this company. | -$5.09M | -$5.92M | 10-K filed 2026-04-15 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. |
| 2024-09-30 | —Revenue: unreported by this company. | —Gross profit: unreported by this company. | -$2.17M | -$2.32M | 10-Q filed 2025-11-14 |
- Assets
- $151.01M
- Equity
- -$27.69M
Balance as of 2026-06-30.
Ten years
| Fiscal year end | Revenue | Operating income | Net income | Free cash flow |
|---|---|---|---|---|
| 2025-12-31 | — | -$27.98M | -$34.66M | -$19.52M |
| 2024-12-31 | — | -$15.66M | -$16.75M | -$13.36M |
| 2023-12-31 | — | -$19.42M | -$18.55M | -$18.11M |
| 2022-12-31 | — | -$18.63M | -$17.56M | -$15.86M |
| 2021-12-31 | — | -$6.15M | -$6.84M | -$5.52M |
| 2020-12-31 | — | -$726,604 | -$2.34M | — |
Company filings
since Thu Apr 30 · 2 offering filings in 12 months
events
Material agreement, Debt accelerated
Material agreementDebt acceleratedOct 18-KOther event
Other eventSep 288-KExecutive or director change
Executive or director changeSep 118-KShareholder rights changed, Bylaws or fiscal year change
Shareholder rights changedBylaws or fiscal year changeAug 38-KShareholder vote results
Shareholder vote resultsJul 208-KShareholder rights changed, Bylaws or fiscal year change
Shareholder rights changedBylaws or fiscal year changeJul 178-K
5% owners ()
DEFJ, LLC
Stake update
Unleash Immuno Oncolytics, Inc.
Passive stake
Elena Rosa Braci
Passive stake
Daniel Eduardo Katzman
Passive stake
DEFJ, LLC
Stake update
Insiders, politicians and funds
Insider trades, last 90 days
No insider buys or sales filed in the last 90 days.
Politician trades, last 90 days
No politician trades filed in the last 90 days.
Funds
None of the tracked funds held this at their last 13F.
News
Stories that named RNAZ, and the market events around them.
Sign in to see thisBoard
Recent signals
Signals open up here once a member has posted about RNAZ.
Signals are informational.
Posts · 0
No posts yet.
nakagai
Signals on RNAZ come from a rule, not a model.
Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.
Members post on the RNAZ board